Chemomab Therapeutics (CMMB) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CMMB Chemomab Therapeutics

Watchlist

1.600
-0.040-2.44%

Close Nov 21 16:00 ET

1.570
-0.030-1.88%

Post 20:01 ET

30.17MMarket Cap-1702P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Chemomab Therapeutics Aligns Leadership Incentives With Shareholders
TipRanksNov 18 16:50 ET
Maxim Group Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Maintains Target Price $4
Moomoo NewsNov 15 15:31 ET · Ratings
Oppenheimer Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Cuts Target Price to $11
Moomoo NewsNov 15 14:31 ET · Ratings
Chemomab Therapeutics Analyst Ratings
BenzingaNov 15 10:53 ET · Ratings
Express News | Chemomab Therapeutics Ltd. : Oppenheimer Cuts Target Price to $11 From $13
ReutersNov 15 08:27 ET
Chemomab Therapeutics Sees Cash Runway Through Beginning of 2026
TipRanksNov 14 07:11 ET

Comments

Jaguar8

Nov 19 06:00

NEWS

$Chemomab Therapeutics (CMMB.US)$
Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis
Chemomab Therapeutics presented Phase 2 SPRING trial data for CM-101 in primary sclerosing cholangitis (PSC) at AASLD The Liver Meeting® 2024.
The trial, involving 76 patients, tested two doses (10 mg/kg and 20 mg/kg) administered every three weeks over 15 w...

Jaguar8

Nov 17 20:12

Presentation tomorrow startkng 5:45PM ET. May have PR coming out

$Chemomab Therapeutics (CMMB.US)$

小竜

Nov 12 11:31

$Chemomab Therapeutics (CMMB.US)$ Let buy some..

Khin8858

Oct 16 03:12

$Chemomab Therapeutics (CMMB.US)$ splendid waited for a while and immediately after I sold to cut loss it bounced lol. guess I am not fated for pharmaceutical any more lol

Trytosaveabit

Oct 15 06:02

Watching for data outadis!

$Chemomab Therapeutics (CMMB.US)$ Reuters
1 min ago
Chemomab Therapeutics Announces Late-Breaking Oral Presentation of Cm-101 Phase 2 Results in Primary Sclerosing Cholangitis at Aasld the Liver Meeting® 2024

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

CMMB Chemomab Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target